Renal cell carcinoma (RCC) is a common malignancy of the urinary tract. In the United States, 81,000 new cases of RCC were diagnosed in 2023, and there were 14,890 related deaths 1. RCC’s grading ...
Efficacy and safety of lenvatinib plus pembrolizumab in patients with advanced renal cell carcinoma and venous tumor thrombus: Results from the first analysis of the PELET trial. This is an ASCO ...
The Cancer Genome Atlas (TCGA) characterized the somatic genetic and genomic alterations in renal cell carcinoma (RCC) encompassing the major RCC histological subtypes, including clear cell RCC (ccRCC ...
Immune checkpoint inhibitors have significantly transformed the treatment paradigm for metastatic renal cell carcinoma (RCC), offering prolonged overall survival and achieving remarkable deep and ...
First described in 1985, chromophobe RCC accounts for approximately 5% of renal tumors.15 This RCC subtype has a better prognosis than either clear cell or papillary RCC, but it is worth noting that ...
RCC contributes to approximately 4% of adult malignancies. To date, four major inherited RCC syndromes have been identified. This PDQ summary provides a reference on the genetics of RCC for clinicians ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results